Latest filing published 14 Aug 2013 for Puramed Bioscience Inc., €819.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Robert S. Libauer discloses dealings in 2 companies, chiefly Puramed Bioscience Inc. and International Monetary Systems Ltd /WI/. In total, 18 filings cover trades dated from 13 May 2011 to 29 July 2013.
On the market, this insider has only ever bought: 17 purchases, €210k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant. Since January 2013: 11 purchases and no sales on the market.
Half of the purchases are above €1,923 and half below.
The newest entry dates from 14 August 2013: an open-market purchase of €819, in Puramed Bioscience Inc. Filings reach the SEC (Form 4) feed a median of 21 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations